The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Long-term exposure to air pollution is tied to an increased risk of having a heart attack or dying from heart disease — with the greatest harms impacting under-resourced communities, new Kaiser Permanente research shows.
Among adults with diabetes who had kidney function perceived to be normal, a marker for early diabetic kidney disease was more commonly seen in Asian adults than in white, Black, or Latino adults, a new Kaiser Permanente study found.
Patients with hypertension and unhealthy alcohol use were more likely to see a decline in their blood pressure if they were asked about their alcohol drinking habits and provided a brief intervention during a visit with their primary care team.
Kaiser Permanente research ties the presence of breast arterial calcification seen on screening mammography to an increased risk of cardiovascular disease.
An analysis by Kaiser Permanente researchers suggests there may be clues in a child’s medical history about their risk for a substance use problem. The investigators used that research and input from parents to develop a free online risk prediction tool that anyone can use.
A new report from a consensus committee headed by Kaiser Permanente Division of Research Director Tracy Lieu, MD, MPH, for the National Academies of Sciences, Engineering and Medicine (NASEM), makes recommendations to accelerate the research needed to fill evidence gaps for clinical preventive services.
KP Research Radio talks to Ai Kubo, PhD, MPH, about her research into why girls are starting puberty earlier than they have in the past, risks associated with early puberty — and potential interventions.
A large, detailed look by Kaiser Permanente researchers at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.
Andy Avins, MD, MPH, has been studying what works, and what doesn't, in medical care ever since a chance encounter in the hospital library with a journal that introduced him to the concept of evidence-based medicine.
